Dr. Celal Gurol Erbay, MD

Dr. Erbay practices at C Gurol Erbay MD PA in Gainesville, Florida.

Dr. Erbay's NPI, 1659380202, was assigned on August 5, 2006. Dr. Erbay graduated from Hacettepe University FOM in 1991. Dr. Erbay holds Florida license ME072025.

Dr. Erbay's primary practice is C Gurol Erbay MD PA, at 7109 Nw 11th Pl, Gainesville, FL 32605 in Alachua County. The practice phone is (352) 333-9909.

Dr. Erbay's primary practice is C Gurol Erbay MD PA in Gainesville, Florida. Dr. Erbay is also affiliated with HCA Florida North Florida Hospital. The medical group on file is C Gurol Erbay, MD PA. Dmand AI also links Dr. Erbay to 2 more home health agencies, 2 hospices, 2 skilled nursing facilities, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Erbay practices, 8 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Erbay's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Erbay is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Erbay's licenses on file in 3 states: Florida, New York and Pennsylvania.

Dmand AI lists acid reflux, acute diabetes, acute sinusitis, alzheimer's disease, aneurysm, anxiety, arteritis and arthritis among the conditions Dr. Erbay treats.

CMS data shows 6,907 Medicare services from Dr. Erbay across 45 procedure codes in 2024, for 263 Medicare patients. Medicare paid $410,811 for them.

CMS counts 263 Medicare patients who saw Dr. Erbay in 2024. The largest group is 65 to 74, with 104 patients. 75% of them have depression, and 75% have diabetes. 43% are also on Medicaid. Their average risk score is 2.27, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Erbay's median patient age at 68, with 46% women.

In 2024, Dr. Erbay wrote 11,478 Medicare Part D claims for 356 patients. 74% of them were for generic drugs. CMS names the drug for 10,534 of them, across 167 drugs with 11 or more claims each, at $1,092,302 in total drug cost. In 2023, CMS named 13,652 claims across 198 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Erbay for performance year 2024, reported individually. Dr. Erbay accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Erbay as offering telehealth. CMS counts 11 procedures of removal of skin lesions by Dr. Erbay, more than 58% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Erbay, published from 2014 to 2018. The most frequent topics are Bioelectric Energy Sources.

CMS Open Payments shows 812 general payments to Dr. Erbay from 49 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. GlaxoSmithKline, LLC. paid the most, $1,556.

Dr. Erbay graduated from Hacettepe University FOM in 1991.

Dr. Erbay is in network with 12 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.